Search Results - "Lever, Ellen"

Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT by Hykin, Philip, Prevost, A Toby, Sivaprasad, Sobha, Vasconcelos, Joana C, Murphy, Caroline, Kelly, Joanna, Ramu, Jayashree, Alshreef, Abualbishr, Flight, Laura, Pennington, Rebekah, Hounsome, Barry, Lever, Ellen, Metry, Andrew, Poku, Edith, Yang, Yit, Harding, Simon P, Lotery, Andrew, Chakravarthy, Usha, Brazier, John

“…Background Licensed ranibizumab (0.5 mg/0.05 ml Lucentis ® ; Novartis International AG, Basel, Switzerland) and aflibercept (2 mg/0.05 ml Eylea ® ; Bayer AG,…”
Get full text

The effect of prunes on stool output, gut transit time and gastrointestinal microbiota: A randomised controlled trial by Lever, Ellen, Scott, S. Mark, Louis, Petra, Emery, Peter W., Whelan, Kevin

“…Prunes (dried plums) are perceived to maintain healthy bowel function, however their effects on gastrointestinal (GI) function are poorly researched and…”
Get full text

Nutrient, fibre, sorbitol and chlorogenic acid content of prunes ( Prunus domestica ): an updated analysis and comparison of different countries of origin and database values by Gill, Samantha K, Lever, Ellen, Emery, Peter W, Whelan, Kevin

“…Current prune composition data are outdated and require a comprehensive and comparative re-analysis. This novel study aimed to: (i) analyse and compare prune…”
Get more information